Market closedNon-fractional
Pulse Biosciences/PLSE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Pulse Biosciences
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
Ticker
PLSE
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Hayward, United States
Employees
56
Website
www.pulsebiosciences.com
PLSE Metrics
BasicAdvanced
$1.1B
Market cap
-
P/E ratio
-$0.81
EPS
1.73
Beta
-
Dividend rate
Price and volume
Market cap
$1.1B
Beta
1.73
Financial strength
Current ratio
7.056
Quick ratio
6.866
Long term debt to equity
21.484
Total debt to equity
24.518
Interest coverage (TTM)
-51.83%
Management effectiveness
Return on assets (TTM)
-46.73%
Return on equity (TTM)
-332.14%
Valuation
Price to book
27.05
Price to tangible book (TTM)
30.89
Price to free cash flow (TTM)
-25.579
Growth
Earnings per share change (TTM)
-43.06%
3-year earnings per share growth (CAGR)
-29.42%
What the Analysts think about PLSE
Analyst Ratings
Majority rating from 2 analysts.
PLSE Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$10M
-15.13%
Profit margin
0.00%
NaN%
PLSE Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q3 22
Q4 22
Q1 23
Q2 23
Q3 23
Actual
-$0.49
-$0.25
-$0.26
-$0.22
-
Expected
-
-
-
-
-$0.22
Surprise
-
-
-
-
-
PLSE News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Pulse Biosciences stock?
Pulse Biosciences (PLSE) has a market cap of $1.1B as of July 27, 2024.
What is the P/E ratio for Pulse Biosciences stock?
The price to earnings (P/E) ratio for Pulse Biosciences (PLSE) stock is 0 as of July 27, 2024.
Does Pulse Biosciences stock pay dividends?
No, Pulse Biosciences (PLSE) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Pulse Biosciences dividend payment date?
Pulse Biosciences (PLSE) stock does not pay dividends to its shareholders.
What is the beta indicator for Pulse Biosciences?
Pulse Biosciences (PLSE) has a beta rating of 1.73. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Pulse Biosciences stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.